A detailed history of State Street Corp transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 2,899,040 shares of PTCT stock, worth $141 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,899,040
Previous 2,749,340 5.44%
Holding current value
$141 Million
Previous $84.1 Million 27.93%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$30.39 - $37.66 $4.55 Million - $5.64 Million
149,700 Added 5.44%
2,899,040 $108 Million
Q2 2024

Aug 14, 2024

SELL
$24.69 - $40.12 $33.6 Million - $54.6 Million
-1,360,452 Reduced 33.1%
2,749,340 $84.1 Million
Q1 2024

May 15, 2024

SELL
$24.15 - $31.95 $12.7 Million - $16.7 Million
-524,163 Reduced 11.31%
4,109,792 $120 Million
Q4 2023

Feb 14, 2024

BUY
$18.07 - $29.37 $26.5 Million - $43 Million
1,465,095 Added 46.23%
4,633,955 $128 Million
Q3 2023

Nov 14, 2023

SELL
$22.41 - $41.99 $36,393 - $68,191
-1,624 Reduced 0.05%
3,168,860 $71 Million
Q2 2023

Aug 14, 2023

BUY
$40.4 - $59.1 $10.7 Million - $15.7 Million
265,351 Added 9.13%
3,170,484 $129 Million
Q1 2023

May 15, 2023

SELL
$38.16 - $48.86 $20.4 Million - $26.1 Million
-533,358 Reduced 15.51%
2,905,133 $141 Million
Q4 2022

Feb 14, 2023

BUY
$33.53 - $54.79 $20.6 Million - $33.7 Million
615,259 Added 21.79%
3,438,491 $131 Million
Q3 2022

Nov 15, 2022

SELL
$41.85 - $53.85 $33.5 Million - $43.2 Million
-801,645 Reduced 22.12%
2,823,232 $142 Million
Q2 2022

Aug 15, 2022

BUY
$25.6 - $45.23 $11.3 Million - $19.9 Million
440,850 Added 13.85%
3,624,877 $145 Million
Q1 2022

May 16, 2022

BUY
$33.33 - $44.6 $12.8 Million - $17.1 Million
382,596 Added 13.66%
3,184,027 $119 Million
Q4 2021

Feb 14, 2022

BUY
$35.36 - $41.86 $5.4 Million - $6.4 Million
152,810 Added 5.77%
2,801,431 $112 Million
Q3 2021

Nov 15, 2021

BUY
$37.01 - $44.74 $10.1 Million - $12.2 Million
271,594 Added 11.43%
2,648,621 $98.6 Million
Q2 2021

Aug 16, 2021

BUY
$37.95 - $49.37 $13.1 Million - $17 Million
345,169 Added 16.99%
2,377,027 $100 Million
Q1 2021

May 17, 2021

SELL
$46.8 - $68.92 $7.01 Million - $10.3 Million
-149,739 Reduced 6.86%
2,031,858 $96.2 Million
Q4 2020

Feb 16, 2021

SELL
$47.96 - $67.64 $4.89 Million - $6.9 Million
-102,011 Reduced 4.47%
2,181,597 $133 Million
Q3 2020

Nov 10, 2020

SELL
$45.41 - $57.07 $2.41 Million - $3.03 Million
-53,175 Reduced 2.28%
2,283,608 $107 Million
Q2 2020

Aug 14, 2020

SELL
$42.56 - $54.98 $1.53 Million - $1.97 Million
-35,894 Reduced 1.51%
2,336,783 $119 Million
Q1 2020

May 11, 2020

BUY
$32.37 - $59.36 $76.8 Million - $141 Million
2,372,677 New
2,372,677 $106 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.48B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.